Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.
Wester CW, Kim S, Bussmann H, Avalos A, Ndwapi N, Peter TF, Gaolathe T, Mujugira A, Busang L, Vanderwarker C, Cardiello P, Johnson O, Thior I, Mazonde P, Moffat H, Essex M, Marlink R. Wester CW, et al. Among authors: thior i. J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):336-43. doi: 10.1097/01.qai.0000159668.80207.5b. J Acquir Immune Defic Syndr. 2005. PMID: 16249709
Mutations and polymorphisms associated with antiretroviral drugs in HIV-1C-infected African patients.
Doualla-Bell F, Gaseitsiwe S, Ndungú T, Modukanele M, Peter T, Novitsky V, Ndwapi N, Tendani G, Avalos A, Wester W, Bussmann H, Cardiello P, Marlink R, Moffat H, Thior I, Wainberg MA, Essex M. Doualla-Bell F, et al. Among authors: thior i. Antivir Chem Chemother. 2004 Jul;15(4):189-200. doi: 10.1177/095632020401500402. Antivir Chem Chemother. 2004. PMID: 15457680 Free article.
HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana.
Bussmann H, Novitsky V, Wester W, Peter T, Masupu K, Gabaitiri L, Kim S, Gaseitsiwe S, Ndungú T, Marlink R, Thior I, Essex M. Bussmann H, et al. Among authors: thior i. Antivir Chem Chemother. 2005;16(2):103-15. doi: 10.1177/095632020501600203. Antivir Chem Chemother. 2005. PMID: 15889533 Free article.
Low adherence to recommended infant feeding strategies among HIV-infected women: results from the pilot phase of a randomized trial to prevent mother-to-child transmission in Botswana.
Shapiro RL, Lockman S, Thior I, Stocking L, Kebaabetswe P, Wester C, Peter T, Marlink R, Essex M, Heymann SJ. Shapiro RL, et al. Among authors: thior i. AIDS Educ Prev. 2003 Jun;15(3):221-30. doi: 10.1521/aeap.15.4.221.23830. AIDS Educ Prev. 2003. PMID: 12866834 Clinical Trial.
Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen.
Doualla-Bell F, Avalos A, Gaolathe T, Mine M, Gaseitsiwe S, Ndwapi N, Novitsky VA, Brenner B, Oliveira M, Moisi D, Moffat H, Thior I, Essex M, Wainberg MA. Doualla-Bell F, et al. Among authors: thior i. Antimicrob Agents Chemother. 2006 Jun;50(6):2210-3. doi: 10.1128/AAC.01447-05. Antimicrob Agents Chemother. 2006. PMID: 16723586 Free PMC article.
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M; Mashi Study Team. Thior I, et al. JAMA. 2006 Aug 16;296(7):794-805. doi: 10.1001/jama.296.7.794. JAMA. 2006. PMID: 16905785 Clinical Trial.
74 results